AGM, EGM Calendar |
Wednesday, June 15 |
Christie Group |
Mytrah Energy |
Kingfisher |
Jimmy Choo |
HSS Hire Group |
Gresham House |
UK Commercial Property Trust |
Manx Telecom |
NetScientific |
MayAir Group |
Thursday, June 16 |
PuriCore |
International Consolidated Airlines Group |
Blur Group |
Evraz |
Serabi Gold |
Blinkx |
Friday, June 17 |
JD Sports Fashion |
Rexam (re recommended offer for Rexam by Ball) |
Charlemagne Capital |
JZ Capital Partners |
Hunters Property |
Zinxox Resources |
Silence Therapeutics |
British & American Investment Trust |
Monday, June 20 |
Electrical Geodesics |
Microsaic Systems |
Silence Therapeutics |
Rasmala |
ValiRx |
Ascent Resources |
DRS Data & Research Services |
CEPS |
Gusbourne |
NetDimensions |
Premier Technical Services |
Tarsus Group |
Management Consulting Group |
Bioquell (approval of tender offer) |
Tuesday, June 21 |
Coca-Cola HBC AG |
Whitbread |
Futura Medical |
Strategic Minerals |
Global Resources Investment Trust |
Saga |
JPMorgan Senior Secured Loan Fund |
Copyright 2016 Alliance News Limited. All Rights Reserved. |
IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia
Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.
Read more